Investing Profile

Veronica Gambillara Fonck

InvestorVC
Partner at Pureos Bioventures
pureosbio.comZurich, Switzerland
Photo of Veronica Gambillara Fonck, Partner at Pureos Bioventures

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Eidgenössische Technische Hochschule Zürich Network
38 CONNECTIONS
ETH Zürich Network
31 CONNECTIONS
IMD Business School Network
22 CONNECTIONS
EPFL (École polytechnique fédérale de Lausanne) Network
19 CONNECTIONS
EPFL Network
14 CONNECTIONS
cb
$100K - $5.0M
$1.5M
4
$205M
CompanyStageDateRound SizeTotal Raised
AnaCardio
Series AJan 2025$18M
$18M
Memo Therapeutics
Series CNov 2023$28M
$75M
Co-investors: Hadrien Bouchez (Kurma Partners), Philippe Dro (Adjuvant Capital)
Minervax
Series UnknownOct 2023$57M
Series CDec 2022$23M
$140M
Co-investors: Christopher Gagliardi (Sanofi Ventures), Kabeer Aziz (Adjuvant Capital), Vincent Brichard
Project Manager EndoArt SAPresent
Manager Clinical Affairs AllerganPresent
Executive Director, Clinical and Regulatory Affairs Glycovaxyn AGPresent
Chairperson of the Board Minervax ApSPresent
CEO-Co-founder LimmaTech Biologics AGPresent
CEO-and Co-Founder GlycoEra AGPresent
Partner Pureos BioventuresPresent
ETH Zürich Engineer Material Engineer
Eidgenössische Technische Hochschule Zürich Engineer Material Engineer
EPFL (École polytechnique fédérale de Lausanne) PhD Biomedical Engineer
EPFL PhD Biomedical Engineer
Management BioTech, BioMed and Pharma Ventures Certificate of Advanced Studies Management BioTech, BioMed and Pharma Ventures
Advanced Course of Vaccinology CME credits Vaccine
IMD Master of Business Administration - MBA Finance, General
IMD Business School Master of Business Administration - MBA Finance, General